Positive News SentimentPositive NewsNASDAQ:SRZN Surrozen (SRZN) Stock Price, News & Analysis $8.61 -0.10 (-1.15%) Closing price 07/14/2025 04:00 PM EasternExtended Trading$8.68 +0.07 (+0.81%) As of 07/14/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Surrozen Stock (NASDAQ:SRZN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Surrozen alerts:Sign Up Key Stats Today's Range$8.35▼$8.9850-Day Range$6.50▼$9.9952-Week Range$5.90▼$18.17Volume2,566 shsAverage Volume22,072 shsMarket Capitalization$73.73 millionP/E RatioN/ADividend YieldN/APrice Target$38.50Consensus RatingBuy Company Overview Surrozen, Inc. (NASDAQ: SRZN) is a clinical-stage biotechnology company focused on the discovery and development of therapeutic antibodies that modulate the Wnt signaling pathway. Founded in 2013 and headquartered in South San Francisco, California, the company leverages its proprietary platform to advance regenerative medicine programs aimed at addressing diseases with high unmet medical need. The company’s lead programs target tissue repair and regeneration in areas such as ophthalmology and liver disease. Surrozen’s pipeline includes antibody candidates designed to selectively activate Wnt co-receptors, which play a critical role in cell proliferation and differentiation. By fine-tuning this pathway, the company aims to restore normal tissue function in conditions characterized by inadequate healing or degeneration. Surrozen’s technology platform integrates advanced molecular engineering with novel screening approaches to generate multispecific antibodies that can precisely control Wnt receptor interactions. This platform has enabled the company to progress multiple preclinical candidates into the clinic, highlighting its commitment to innovative biologics discovery and translational research. Led by CEO David Hall, Surrozen operates with a management team that brings expertise in antibody engineering, translational biology, and clinical development. While based in the San Francisco Bay Area, the company collaborates with academic institutions and strategic partners globally to support its research efforts and accelerate the development of potential therapies for patients worldwide.AI Generated. May Contain Errors. Read More Surrozen Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks56th Percentile Overall ScoreSRZN MarketRank™: Surrozen scored higher than 56% of companies evaluated by MarketBeat, and ranked 507th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingSurrozen has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageSurrozen has only been the subject of 1 research reports in the past 90 days.Read more about Surrozen's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Surrozen are expected to decrease in the coming year, from ($8.49) to ($10.71) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Surrozen is -0.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Surrozen is -0.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Surrozen's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted1.51% of the float of Surrozen has been sold short.Short Interest Ratio / Days to CoverSurrozen has a short interest ratio ("days to cover") of 5.Change versus previous monthShort interest in Surrozen has recently increased by 47.55%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSurrozen does not currently pay a dividend.Dividend GrowthSurrozen does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.51% of the float of Surrozen has been sold short.Short Interest Ratio / Days to CoverSurrozen has a short interest ratio ("days to cover") of 5.Change versus previous monthShort interest in Surrozen has recently increased by 47.55%, indicating that investor sentiment is decreasing significantly. News and Social Media3.3 / 5News SentimentN/A News SentimentSurrozen has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Surrozen this week, compared to 0 articles on an average week. Company Ownership3.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Surrozen insiders have not sold or bought any company stock.Percentage Held by Insiders45.18% of the stock of Surrozen is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions66.57% of the stock of Surrozen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Surrozen's insider trading history. Receive SRZN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Surrozen and its competitors with MarketBeat's FREE daily newsletter. Email Address SRZN Stock News HeadlinesWe Think Surrozen (NASDAQ:SRZN) Can Afford To Drive Business GrowthJuly 1, 2025 | finance.yahoo.comSurrozen secures patent for tissue repair technologyMay 15, 2025 | investing.comThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history. | Paradigm Press (Ad)Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt PathwayMay 14, 2025 | globenewswire.comSurrozen, Inc.: Surrozen Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 10, 2025 | finanznachrichten.deSurrozen Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 9, 2025 | globenewswire.comSurrozen files to sell 5.21M shares of common stock for holdersApril 25, 2025 | markets.businessinsider.comSurrozen reports FY24 EPS ($21.67) vs. ($21.33) last yearApril 2, 2025 | markets.businessinsider.comSee More Headlines SRZN Stock Analysis - Frequently Asked Questions How have SRZN shares performed this year? Surrozen's stock was trading at $14.35 at the beginning of the year. Since then, SRZN shares have decreased by 40.0% and is now trading at $8.61. How were Surrozen's earnings last quarter? Surrozen, Inc. (NASDAQ:SRZN) released its quarterly earnings data on Friday, May, 9th. The company reported ($3.13) EPS for the quarter, missing analysts' consensus estimates of ($1.09) by $2.04. The firm earned $0.98 million during the quarter. When did Surrozen's stock split? Shares of Surrozen reverse split on Thursday, December 14th 2023.The 1-15 reverse split was announced on Thursday, December 14th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. How do I buy shares of Surrozen? Shares of SRZN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Surrozen own? Based on aggregate information from My MarketBeat watchlists, some other companies that Surrozen investors own include ACADIA Pharmaceuticals (ACAD), Marvell Technology (MRVL), HubSpot (HUBS), Avidity Biosciences (RNA), Adverum Biotechnologies (ADVM), Alpha and Omega Semiconductor (AOSL) and Company Calendar Last Earnings5/09/2025Today7/14/2025Next Earnings (Estimated)8/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:SRZN CIK1824893 Webwww.consonancehfw.com Phone650-489-9000FaxN/AEmployees80Year FoundedN/APrice Target and Rating Average Price Target for Surrozen$38.50 High Price Target$45.00 Low Price Target$32.00 Potential Upside/Downside+347.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($24.96) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$63.56 million Net MarginsN/A Pretax Margin-702.04% Return on Equity-842.90% Return on Assets-71.32% Debt Debt-to-Equity RatioN/A Current Ratio10.02 Quick Ratio10.02 Sales & Book Value Annual Sales$11.64 million Price / Sales6.34 Cash FlowN/A Price / Cash FlowN/A Book Value($6.55) per share Price / Book-1.31Miscellaneous Outstanding Shares8,563,000Free Float4,838,000Market Cap$73.73 million OptionableNot Optionable Beta0.59 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (NASDAQ:SRZN) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surrozen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surrozen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.